| May 17, 2024 |
May 21, 2024 |
NEUROCRINE BIOSCIENCES INC
|
Director |
Sell |
10.0
|
-1,106
|
-52.67%
|
✓
|
$156.9K |
| Oct 14, 2020 |
Oct 16, 2020 |
Ultragenyx Pharmaceutical Inc.
|
EVP, Finance |
Sell |
51.3
|
-375
|
-0.38%
|
✗
|
$33K |
| Aug 17, 2020 |
Aug 19, 2020 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
17.5
|
-14,378
|
-2.83%
|
✗
|
$1.3M |
| Jun 3, 2020 |
Jun 5, 2020 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
20.0
|
-12,798
|
-5.95%
|
✗
|
$949.4K |
| Jun 1, 2020 |
Jun 3, 2020 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
51.3
|
-348
|
-0.34%
|
✗
|
$24.1K |
| May 18, 2020 |
May 20, 2020 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
17.5
|
-29,113
|
-6.68%
|
✗
|
$2.1M |
| May 6, 2020 |
May 8, 2020 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
51.3
|
-248
|
-0.24%
|
✗
|
$16.4K |
| Apr 19, 2020 |
Apr 21, 2020 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
51.3
|
-248
|
-0.24%
|
✗
|
$14.5K |
| Mar 1, 2020 |
Mar 3, 2020 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
87.5
|
+3,309
|
3.29%
|
✗
|
$130.4K |
| Jun 1, 2019 |
Jun 4, 2019 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
48.8
|
-346
|
-0.51%
|
✗
|
$19K |
| May 21, 2019 |
May 22, 2019 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
48.8
|
-381
|
-0.56%
|
✗
|
$22.7K |
| Apr 19, 2019 |
Apr 23, 2019 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
51.3
|
-248
|
-0.37%
|
✗
|
$16K |
| Mar 18, 2019 |
Apr 17, 2019 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
15.0
|
-14,800
|
-18.24%
|
✓
|
$1M |
| Mar 1, 2019 |
Apr 17, 2019 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
95.0
|
+6,988
|
11.25%
|
✗
|
$66.3K |
| Mar 18, 2019 |
Mar 20, 2019 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
15.0
|
-14,800
|
-18.24%
|
✓
|
$1M |
| Mar 1, 2019 |
Mar 4, 2019 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
95.0
|
+7,019
|
11.30%
|
✗
|
$66.3K |
| Sep 25, 2018 |
Sep 27, 2018 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
22.5
|
-6,700
|
-11.79%
|
✓
|
$603.5K |
| Jun 7, 2018 |
Jun 7, 2018 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
22.5
|
-6,700
|
-11.13%
|
✓
|
$536.5K |
| Jun 1, 2018 |
Jun 4, 2018 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
48.8
|
-346
|
-0.61%
|
✗
|
$25.5K |
| May 30, 2018 |
May 30, 2018 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
17.5
|
-13,000
|
-18.53%
|
✓
|
$912.2K |
| May 21, 2018 |
May 22, 2018 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
48.8
|
-381
|
-0.59%
|
✗
|
$24.7K |
| Mar 1, 2018 |
Mar 5, 2018 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
91.3
|
+6,603
|
11.90%
|
✗
|
$19.2K |
| Jun 1, 2017 |
Jun 1, 2017 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
48.8
|
-376
|
-0.67%
|
✗
|
$21.3K |
| May 21, 2017 |
May 22, 2017 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
48.8
|
-414
|
-0.74%
|
✗
|
$23.8K |
| Mar 2, 2017 |
Mar 3, 2017 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
15.0
|
-12,000
|
-17.68%
|
✓
|
$1.1M |
| Feb 27, 2017 |
Feb 28, 2017 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
17.5
|
-12,000
|
-18.78%
|
✓
|
$961.7K |
| Nov 9, 2016 |
Nov 10, 2016 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
5.0
|
-24,000
|
-34.59%
|
✓
|
$1.7M |
| Oct 19, 2016 |
Oct 21, 2016 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
12.5
|
-12,000
|
-20.91%
|
✓
|
$736.8K |
| May 21, 2016 |
May 24, 2016 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
48.8
|
-414
|
-0.99%
|
✗
|
$26.5K |
| Dec 10, 2015 |
Dec 14, 2015 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
10.0
|
-12,000
|
-22.30%
|
✓
|
$1.2M |
| Jul 20, 2015 |
Jul 22, 2015 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
26.3
|
-3,854
|
-8.44%
|
✓
|
$508.5K |
| Jul 20, 2015 |
Jul 22, 2015 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
26.3
|
-3,854
|
-8.44%
|
✓
|
$508.5K |
| Jun 18, 2015 |
Jun 19, 2015 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
26.3
|
-4,000
|
-8.06%
|
✓
|
$384.3K |
| May 18, 2015 |
May 20, 2015 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
26.3
|
-4,000
|
-8.12%
|
✓
|
$317.7K |
| Apr 20, 2015 |
Apr 22, 2015 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
28.8
|
-4,000
|
-7.65%
|
✓
|
$248.9K |
| Mar 18, 2015 |
Mar 20, 2015 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
32.5
|
-4,000
|
-7.11%
|
✓
|
$245.8K |
| Feb 18, 2015 |
Feb 20, 2015 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
32.5
|
-4,000
|
-6.64%
|
✓
|
$215.9K |
| Jan 20, 2015 |
Jan 22, 2015 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
32.5
|
-4,000
|
-6.23%
|
✓
|
$205K |
| Dec 18, 2014 |
Dec 22, 2014 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
32.5
|
-4,000
|
-5.86%
|
✓
|
$179.3K |
| Nov 20, 2014 |
Nov 21, 2014 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
32.5
|
-4,000
|
-5.54%
|
✓
|
$176.3K |
| Oct 20, 2014 |
Oct 22, 2014 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
32.5
|
-4,000
|
-5.25%
|
✓
|
$184.1K |
| Sep 18, 2014 |
Sep 19, 2014 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
37.5
|
-4,000
|
-4.98%
|
✓
|
$224K |
| Aug 18, 2014 |
Aug 19, 2014 |
Ultragenyx Pharmaceutical Inc.
|
CFO |
Sell |
37.5
|
-4,000
|
-4.75%
|
✓
|
$215.9K |